TickerFacts.

Anavex Life Sciences Corp. (AVXL): Operating Income

Annual figures by period end, from SEC filings.

-$51.41M
Year ended 2025-09-30
-$17.37M
Trailing 12 months to 2026-06-30
2010-09-30: -$5.65M2011-09-30: -$6.18M2012-09-30: -$4.32M2013-09-30: -$2.14M2014-09-30: -$2.97M2020-09-30: -$31.09M2021-09-30: -$42.00M2022-09-30: -$50.99M2023-09-30: -$55.76M2024-09-30: -$52.88M2025-09-30: -$51.41M-$51.41M
2010-09-30 Operating Income (USD) 2025-09-30
Period endedOperating IncomeChange YoYSource filing
2025-09-30-$51.41Mn/m2026-08-28, From 2024-10-01
2024-09-30-$52.88Mn/m2026-08-28, From 2023-10-01
2023-09-30-$55.76Mn/m2026-08-28, From 2022-10-01
2022-09-30-$50.99Mn/m2023-11-27, From 2021-10-01
2021-09-30-$42.00Mn/m2023-11-27, From 2020-10-01
2020-09-30-$31.09Mn/a2022-11-28, From 2019-10-01
No annual figure between 2014-09-30 and 2020-09-30.
2014-09-30-$2.97Mn/m2014-12-29, From 2013-10-01
2013-09-30-$2.14Mn/m2014-12-29, From 2012-10-01
2012-09-30-$4.32Mn/m2013-12-30, From 2011-10-01
2011-09-30-$6.18Mn/m2012-12-31, From 2010-10-01
2010-09-30-$5.65Mn/a2011-12-22, From 2009-10-01

Operating Income at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Anavex Life Sciences Corp. (AVXL)2025-09-30-$51.41Mn/m
Surrozen, Inc. (SRZN)2025-12-31-$42.09Mn/m
Lineage Cell Therapeutics, Inc. (LCTX)2025-12-31-$36.62Mn/m
Zura Bio Ltd (ZURA)2025-12-31-$75.25Mn/m
Quince Therapeutics, Inc. (QNCX)2025-12-31-$58.07Mn/m
aTYR PHARMA INC (ATYR)2025-12-31-$77.63Mn/m
Humacyte, Inc. (HUMA)2025-12-31-$108.14Mn/m
LeonaBio, Inc. (LONA)2025-12-31-$102.27Mn/m
Aligos Therapeutics, Inc. (ALGS)2025-12-31-$87.98Mn/m

Compare AVXL, SRZN, LCTX, ZURA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗